Amy Parison, SVP, Chief Financial Officer at Editas Medicine, Inc. (EDIT), sold 474 shares at $2.02 ($957) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Open-market sale of $957 EDIT by SVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EDIT | SELL | 2026-06-05 | $1K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $991 | — | Filing → |
| EDIT | SELL | 2025-09-04 | $1K | — | Filing → |